Print

Serologicals Corporation (SERO) Announces Completion of Acquisition Of AltaGen Biosciences And Sierra BioSource Subsidiary 
10/19/2005 5:11:27 PM

Serologicals Corporation (NASDAQ: SERO) announced today that it has completed its previously announced acquisition of AltaGen Biosciences, Inc., the parent company of Sierra BioSource(TM), a leading provider of contract research and development services to the cell culture industry.